Aloxi Solution For Injection 0.05Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Aloxi: Solution for injection (0.05mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PALONOSETRON (pal oh NOE se tron) is used to prevent nausea and vomiting caused by chemotherapy. It also helps prevent delayed nausea and vomiting that may occur a few days after your treatment.

In-Depth Information
Select a Medication

Aloxi 0.25mg/5ml Solution for Injection

NDC: 580630797
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Post-operative Nausea/vomiting (PONV) Prophylaxis, Chemotherapy-induced Nausea/vomiting Prophylaxis

Storage Information
Protect from light
Protect from freezing
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Aloxi 0.25mg/5ml Solution for Injection

Reported Side Effects for Aloxi 0.25mg/5ml Solution for Injection

Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Electrolyte Imbalance Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Retaining Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Increased Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Eye Irritation Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Chills Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Dyskinesia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elated Mood Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Glycosuria Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hiccups Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Shallow, Slow Breathing Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Injection Site Reaction Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Vocal Cord Spasm Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Lazy Eye Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Allergic Skin Reaction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
<9.0%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Extra Saliva Production Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Low Potassium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Long Qt Syndrome Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: RAPID
Itching Incidence:
1.0%*
Severity: MILD
Onset: RAPID
High Potassium Level Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Slow Heart Beat Incidence:
1.0%*
Severity: SEVERE
Onset: RAPID
Nervousness Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Aloxi

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5